KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $701,415 | +110533.3% | 77,935 | -3.4% | 0.00% | – |
| Q1 2023 | $634 | -83.7% | 80,703 | -86.0% | 0.00% | -100.0% |
| Q4 2022 | $3,895 | -99.9% | 576,251 | +20.6% | 0.00% | -50.0% |
| Q3 2022 | $6,935,000 | +602.6% | 477,958 | +376.4% | 0.00% | +300.0% |
| Q2 2022 | $987,000 | +290.1% | 100,317 | +485.0% | 0.00% | – |
| Q1 2022 | $253,000 | -60.5% | 17,148 | -53.3% | 0.00% | – |
| Q3 2021 | $641,000 | +17.2% | 36,715 | +27.5% | 0.00% | – |
| Q4 2020 | $547,000 | -30.8% | 28,797 | -54.1% | 0.00% | -100.0% |
| Q3 2020 | $790,000 | +37.6% | 62,778 | +32.3% | 0.00% | 0.0% |
| Q2 2020 | $574,000 | +14.6% | 47,462 | +68.6% | 0.00% | 0.0% |
| Q4 2019 | $501,000 | +205.5% | 28,148 | +98.0% | 0.00% | – |
| Q3 2019 | $164,000 | -25.1% | 14,219 | +43.7% | 0.00% | – |
| Q2 2019 | $219,000 | -92.1% | 9,895 | -89.7% | 0.00% | -100.0% |
| Q1 2019 | $2,761,000 | +139.9% | 96,470 | +85.4% | 0.00% | +300.0% |
| Q3 2018 | $1,151,000 | +975.7% | 52,041 | +296.7% | 0.00% | – |
| Q2 2018 | $107,000 | -95.1% | 13,117 | -94.3% | 0.00% | -100.0% |
| Q1 2018 | $2,173,000 | -5.8% | 229,248 | -3.1% | 0.00% | 0.0% |
| Q4 2017 | $2,307,000 | – | 236,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |